Influence of control group design on outcome in recent antipsychotic clinical trials for schizophrenia

被引：0
|
作者：
Woods, SW [1 ]
Gueorguieva, RV [1 ]
Makuch, RW [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT 06519 USA
来源：
SCHIZOPHRENIA RESEARCH | 2002年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Metabolic deterioration of the sedentary control group in clinical trials
    Patel, Mahesh J.
    Slentz, Cris A.
    Kraus, William E.
    JOURNAL OF APPLIED PHYSIOLOGY, 2011, 111 (04) : 1211 - 1217
  • [42] WHICH OUTCOME INDICES WOULD CLINICIANS LIKE TO SEE IN SCHIZOPHRENIA CLINICAL TRIALS?
    Galderisi, S.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [43] Design and analysis of group-randomized trials: A review of recent practices
    Varnell, SP
    Murray, DM
    Janega, JB
    Blitstein, JL
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (03) : 393 - 399
  • [44] Design and analysis of group-randomized trials: A review of recent developments
    Murray, DM
    ANNALS OF EPIDEMIOLOGY, 1997, 7 (07) : S69 - S77
  • [45] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Palmer, B
    Harvey, PD
    Davis, S
    McEvoy, J
    Golberg, T
    Gold, J
    Green, MF
    Swartz, MS
    Stroup, S
    Rosenheck, R
    Perkins, D
    Meltzer, H
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 79S - 79S
  • [46] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Harvey, PD
    Davis, S
    Palmer, B
    McEvoy, JP
    Goldberg, TE
    Gold, JM
    Green, MR
    Swartz, M
    Stroup, S
    Rosenheck, R
    Perkins, DO
    Meltzer, HY
    Miller, D
    Canive, J
    Walker, TM
    Lieberman, JA
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 361 - 362
  • [47] The relationship between suicide and violence in schizophrenia: Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset
    Witt, Katrina
    Hawton, Keith
    Fazel, Seena
    SCHIZOPHRENIA RESEARCH, 2014, 154 (1-3) : 61 - 67
  • [48] Comparison of Adaptive Design and Parallel Control Design in Clinical Trials
    Wang Jiu
    Wang Suzhen
    RECENT ADVANCE IN STATISTICS APPLICATION AND RELATED AREAS, PTS 1 AND 2, 2011, : 1176 - +
  • [49] A three-outcome design for phase II clinical trials
    Sargent, DJ
    Chan, V
    Goldberg, RM
    CONTROLLED CLINICAL TRIALS, 2001, 22 (02): : 117 - 125
  • [50] Appropriate design and outcome measures in multiple sclerosis clinical trials
    Greenstein, JI
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (05) : 503 - 504
12345